Gorgojo Juan, Harvill Eric T, Rodríguez Maria Eugenia
CINDEFI (UNLP CONICET La Plata), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina.
Department of Veterinary and Biomedical Science, The Pennsylvania State University, University Park, Pennsylvania, USA.
Infect Immun. 2014 Dec;82(12):5175-84. doi: 10.1128/IAI.02553-14. Epub 2014 Sep 29.
Bordetella parapertussis is a human pathogen that causes whooping cough. The increasing incidence of B. parapertussis has been attributed to the lack of cross protection induced by pertussis vaccines. It was previously shown that B. parapertussis is able to avoid bacterial killing by polymorphonuclear leukocytes (PMN) if specific opsonic antibodies are not present at the site of interaction. Here, we evaluated the outcome of B. parapertussis innate interaction with human macrophages, a less aggressive type of cell and a known reservoir of many persistent pathogens. The results showed that in the absence of opsonins, O antigen allows B. parapertussis to inhibit phagolysosomal fusion and to remain alive inside macrophages. The O antigen targets B. parapertussis to lipid rafts that are retained in the membrane of phagosomes that do not undergo lysosomal maturation. Forty-eight hours after infection, wild-type B. parapertussis bacteria but not the O antigen-deficient mutants were found colocalizing with lipid rafts and alive in nonacidic compartments. Taken together, our data suggest that in the absence of opsonic antibodies, B. parapertussis survives inside macrophages by preventing phagolysosomal maturation in a lipid raft- and O antigen-dependent manner. Two days after infection, about 15% of macrophages were found loaded with live bacteria inside flotillin-enriched phagosomes that had access to nutrients provided by the host cell recycling pathway, suggesting the development of an intracellular infection. IgG opsonization drastically changed this interaction, inducing efficient bacterial killing. These results highlight the need for B. parapertussis opsonic antibodies to induce bacterial clearance and prevent the eventual establishment of cellular reservoirs of this pathogen.
副百日咳博德特氏菌是一种引起百日咳的人类病原体。副百日咳博德特氏菌发病率的上升归因于百日咳疫苗诱导的交叉保护作用的缺乏。先前的研究表明,如果在相互作用部位不存在特异性调理抗体,副百日咳博德特氏菌能够避免被多形核白细胞(PMN)杀灭。在此,我们评估了副百日咳博德特氏菌与人类巨噬细胞先天性相互作用的结果,巨噬细胞是一种攻击性较弱的细胞类型,也是许多持续性病原体的已知储存库。结果表明,在没有调理素的情况下,O抗原可使副百日咳博德特氏菌抑制吞噬溶酶体融合并在巨噬细胞内存活。O抗原将副百日咳博德特氏菌靶向定位于吞噬体膜中保留的脂筏,这些吞噬体不会经历溶酶体成熟。感染48小时后,发现野生型副百日咳博德特氏菌细菌而非O抗原缺陷型突变体与脂筏共定位并存活于非酸性区室中。综上所述,我们的数据表明,在没有调理抗体的情况下,副百日咳博德特氏菌通过以脂筏和O抗原依赖的方式阻止吞噬溶酶体成熟而在巨噬细胞内存活。感染两天后,发现约15%的巨噬细胞内充满了活细菌,这些细菌存在于富含小窝蛋白的吞噬体中,这些吞噬体可获取宿主细胞循环途径提供的营养,这表明发生了细胞内感染。IgG调理作用极大地改变了这种相互作用,诱导了有效的细菌杀灭。这些结果凸显了副百日咳博德特氏菌调理抗体对于诱导细菌清除以及防止该病原体最终建立细胞储存库的必要性。